Search results

Records found: 3  
Your query: Subject (keywords) = "anlotinib"

  1. 1.Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells

    TitleAnlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells
    Author infoYan Xu, Ji Zheng, Zhi-Ying Ye
    Author Xu Yan
    Co-authors Zheng Ji
    Ye Zhi-Ying
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1119-1128  : ilustr., fareb. grafy, obr.
    MeSH Subject nádory prostaty
    proteíntyrozínkinázy : antagonisty a inhibítory
    procesy nádorové
    línia bunková nádorová
    Subj. Headings anlotinib * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  2. 2.Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway

    TitleAnlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway
    Author infoMin Yuan ... [et al.]
    Co-authors Yuan Min
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 4 (2022), s. 807-819  : ilustr., aj fareb., grafy, obr.
    MeSH Subject nádory žalúdka
    proteíntyrozínkinázy : antagonisty a inhibítory
    antigén B7-H1
    procesy nádorové
    línia bunková nádorová
    testy protinádorového účinku na xenoimplantátových modeloch
    Subj. Headings anlotinib - použitie terapeutické * expresia PD-L1 * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  3. 3.Third-line treatment for metastatic colorectal cancer: anlotinib is superior to chemotherapy and similar to fruquintinib or regorafenib

    TitleThird-line treatment for metastatic colorectal cancer: anlotinib is superior to chemotherapy and similar to fruquintinib or regorafenib
    Author infoY. Cheng ... [et al.]
    Co-authors Cheng Y.
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2020 . - Vol. 67, no. 6 (2020), s. 1384-1390  : ilustr., grafy, tab.
    MeSH Subject nádory kolorektálne : farmakoterapia
    metastázy nádorové
    antineoplastiká imunologické : použitie terapeutické : aplikácia a dávkovanie
    výsledok liečby
    Subj. Headings liečba 3.línie * anlotinib * vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all